![](/images/graphics-bg.png)
Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women
Joint Authors
Haddad, Lisa B.
Zahedi-Spung, Leilah
Young, Marisa
Badell, Martina L.
Source
Infectious Diseases in Obstetrics and Gynecology
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-10-16
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Introduction.
Although rare, perinatal HIV transmission still occurs in the United States and most transmissions are preventable.
We aim to identify patient barriers to antiretroviral therapy (ART) adherence during pregnancy and assess patient understanding of perinatal transmission.
Methods.
This cross-sectional survey recruited HIV positive postpartum women at a large safety net hospital in Atlanta, Georgia, between January 2016 and February 2018.
Survey questions included demographic characteristics, HIV history, knowledge of perinatal transmission, and ART adherence.
Perinatal and HIV outcomes were assessed using chart abstraction.
Results.
Of the 70 HIV infected postpartum women delivered at a large safety net hospital in Atlanta, GA, 45 women were eligible and consented to participate.
Participating women were aged 18 to 40 years with an average age of 29 years old, 93% of participants were African-American, and 68% had ≥3 pregnancies.
The majority of participants (75%) reported daily ART adherence.
“Forgetting” was the most frequent reason for missing pills (57%).
Thirteen women had a detectable viral load at the time of delivery and nine of those women had a viral load greater than 1000 copies/mL.
Approximately 85% of women who correctly stated ART medications decrease perinatal transmission risk reported daily adherence compared with 50% of women without that knowledge (OR 5.6, 95% CI 1.17, 26.7).
Almost half of women (40%) either did not know or believed a vaginal delivery, regardless of viral load, would increase their risk of perinatal transmission.
Conclusion.
Overall, women who were diagnosed with HIV during the current pregnancy, those with planned pregnancies, and those who were on medications prior to pregnancy were more likely to report daily ART adherence.
Detectable viral load at delivery is the greatest risk factor for perinatal transmission; therefore strategies to increase ART adherence are needed.
American Psychological Association (APA)
Zahedi-Spung, Leilah& Young, Marisa& Haddad, Lisa B.& Badell, Martina L.. 2018. Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women. Infectious Diseases in Obstetrics and Gynecology،Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1166070
Modern Language Association (MLA)
Zahedi-Spung, Leilah…[et al.]. Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women. Infectious Diseases in Obstetrics and Gynecology No. 2018 (2018), pp.1-5.
https://search.emarefa.net/detail/BIM-1166070
American Medical Association (AMA)
Zahedi-Spung, Leilah& Young, Marisa& Haddad, Lisa B.& Badell, Martina L.. Perceived Barriers to Antepartum HIV Medication Adherence in HIV Infected Pregnant Women. Infectious Diseases in Obstetrics and Gynecology. 2018. Vol. 2018, no. 2018, pp.1-5.
https://search.emarefa.net/detail/BIM-1166070
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1166070